Gencurix Inc. (KOSDAQ: 229000)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,660.00
+5.00 (0.19%)
Sep 11, 2024, 2:20 PM KST

Gencurix Statistics

Total Valuation

Gencurix has a market cap or net worth of KRW 40.47 billion. The enterprise value is 48.42 billion.

Market Cap 40.47B
Enterprise Value 48.42B

Important Dates

The next estimated earnings date is Thursday, November 14, 2024.

Earnings Date Nov 14, 2024
Ex-Dividend Date n/a

Share Statistics

Gencurix has 15.24 million shares outstanding. The number of shares has increased by 49.46% in one year.

Shares Outstanding 15.24M
Shares Change (YoY) +49.46%
Shares Change (QoQ) +1.15%
Owned by Insiders (%) 15.28%
Owned by Institutions (%) 7.74%
Float 11.12M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 12.63
PB Ratio 3.61
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -3.40
EV / Sales 16.61
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -4.28

Financial Position

The company has a current ratio of 0.22, with a Debt / Equity ratio of 125.39.

Current Ratio 0.22
Quick Ratio 0.15
Debt / Equity 125.39
Debt / EBITDA n/a
Debt / FCF -0.95
Interest Coverage -17.01

Financial Efficiency

Return on equity (ROE) is -112.87% and return on invested capital (ROIC) is -26.91%.

Return on Equity (ROE) -112.87%
Return on Assets (ROA) -23.43%
Return on Capital (ROIC) -26.91%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.10
Inventory Turnover 1.70

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -62.64% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -62.64%
50-Day Moving Average 2,855.80
200-Day Moving Average 3,877.95
Relative Strength Index (RSI) 44.20
Average Volume (20 Days) 1,590,358

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Gencurix had revenue of KRW 2.91 billion and -14.25 billion in losses. Loss per share was -1,027.57.

Revenue 2.91B
Gross Profit 1.71B
Operating Income -11.42B
Pretax Income -15.13B
Net Income -14.25B
EBITDA -10.00B
EBIT -11.42B
Loss Per Share -1,027.57
Full Income Statement

Balance Sheet

The company has 773.79 million in cash and 10.75 billion in debt, giving a net cash position of -9.97 billion or -654.29 per share.

Cash & Cash Equivalents 773.79M
Total Debt 10.75B
Net Cash -9.97B
Net Cash Per Share -654.29
Equity (Book Value) 8.57B
Book Value Per Share 734.60
Working Capital -10.06B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -9.26 billion and capital expenditures -2.05 billion, giving a free cash flow of -11.31 billion.

Operating Cash Flow -9.26B
Capital Expenditures -2.05B
Free Cash Flow -11.31B
FCF Per Share -741.62
Full Cash Flow Statement

Margins

Gross Margin 58.76%
Operating Margin -391.78%
Pretax Margin -519.31%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin -387.92%

Dividends & Yields

Gencurix does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -49.46%
Shareholder Yield -49.46%
Earnings Yield -38.70%
FCF Yield -27.93%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a